Table 1.
Descriptive information about sample
| M | SD | % | |
|---|---|---|---|
| Child age | 14.12 | 2.07 | |
| Gender – male | 57 | ||
| Ethnicity | |||
| Caucasian | 49 | ||
| African American | 25 | ||
| Asian | 13 | ||
| Hispanic | 11 | ||
| Other | 2 | ||
| Beta agonist | 96 | ||
| Inhaled corticosteroid | 71 | ||
| Parent childhood SES – rent | 46 | ||
| Current family SES | 5.00 | 2.74 | |
| Family stress | 2.19 | 0.76 | |
| Asthma control (Child report) | 20.84 | 3.54 | |
| Asthma control (Parent report) | 19.85 | 3.34 | |
| Poly I:C | −0.01 | 0.94 | |
| LPS | 0.00 | 0.91 | |
| PMA/INO (Th-1) | 0.00 | 0.94 | |
| PMA/INO (Th-2) | 0.00 | 0.90 | |
Note: Beta agonist and inhaled corticosteroid use refers to the % who have a current prescription for that medication. Current family SES ranges from 1–9, with a 5 corresponding to $20,000-$49,999. Family stress ranges from 1–5. Asthma control ranges from 5–25. LPS=lipopolysaccharide. PMA/INO = phorbol myristate acetate/ionomycin. Cytokine production is represented by composite indicators derived from factor analyses. They include a Th-2 factor (IL-2, 4, 5, and 13), a Th-1 factor (IFN-γ, IL-10), and a pro-inflammatory factor (IL-1β, IL-6, TNF-α). In all cases, values are corrected for non-specific production of each cytokine, then standardized and aggregated into composites.